CISATRACURIUM AJS cisatracurium (as besilate) 20mg/10mL injection solution in vial Australia - English - Department of Health (Therapeutic Goods Administration)

cisatracurium ajs cisatracurium (as besilate) 20mg/10ml injection solution in vial

southern cross pharma pty ltd - cisatracurium besilate, quantity: 2.68 mg/ml (equivalent: cisatracurium, qty 2 mg/ml) - injection, solution - excipient ingredients: benzenesulfonic acid; water for injections - during surgical and other procedures and in intensive care to relax skeletal muscles, and to faciliate tracheal intubation and mechanical ventilation. an adjunct to general anaesthesia, or sedation in intensive care units

CISATRACURIUM AJS cisatracurium (as besilate) 10mg/5mL injection solution in vial Australia - English - Department of Health (Therapeutic Goods Administration)

cisatracurium ajs cisatracurium (as besilate) 10mg/5ml injection solution in vial

southern cross pharma pty ltd - cisatracurium besilate, quantity: 2.68 mg/ml (equivalent: cisatracurium, qty 2 mg/ml) - injection, solution - excipient ingredients: benzenesulfonic acid; water for injections - during surgical and other procedures and in intensive care to relax skeletal muscles, and to faciliate tracheal intubation and mechanical ventilation. an adjunct to general anaesthesia, or sedation in intensive care units.

DBL ATRACURIUM BESYLATE 50mg/5mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

dbl atracurium besylate 50mg/5ml injection ampoule

pfizer australia pty ltd - atracurium besilate, quantity: 50 mg - injection - excipient ingredients: benzenesulfonic acid; water for injections - atracurium besylate injection is indicated as an adjunct to general anaesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

DBL ATRACURIUM BESYLATE 25mg/2.5mL injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

dbl atracurium besylate 25mg/2.5ml injection ampoule

pfizer australia pty ltd - atracurium besilate, quantity: 25 mg - injection - excipient ingredients: benzenesulfonic acid; water for injections - atracurium besylate injection is indicated as an adjunct to general anaesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

DBL CISATRACURIUM INJECTION CONCENTRATE cisatracurium (as besilate) 10 mg/5 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

dbl cisatracurium injection concentrate cisatracurium (as besilate) 10 mg/5 ml solution for injection vial

pfizer australia pty ltd - cisatracurium besilate -

DBL CISATRACURIUM INJECTION CONCENTRATE cisatracurium (as besilate) 5 mg/2.5 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

dbl cisatracurium injection concentrate cisatracurium (as besilate) 5 mg/2.5 ml solution for injection vial

pfizer australia pty ltd - cisatracurium besilate -

Atracurium Kalceks 10 mg/ml inj./inf. sol. i.v. amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

atracurium kalceks 10 mg/ml inj./inf. sol. i.v. amp.

as kalceks a.s. - atracurium besilate 10 mg/ml - solution for injection/infusion - 10 mg/ml - atracurium besilate 10 mg/ml - atracurium

Atracurium Kalceks 10 mg/ml inj./inf. sol. i.v. amp. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

atracurium kalceks 10 mg/ml inj./inf. sol. i.v. amp.

as kalceks a.s. - atracurium besilate 10 mg/ml - solution for injection/infusion - 10 mg/ml - atracurium besilate 10 mg/ml - atracurium

CISATRACURIUM MYLAN cisatracurium (as besilate) 150 mg/30 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

cisatracurium mylan cisatracurium (as besilate) 150 mg/30 ml solution for injection vial

medtas pty ltd - cisatracurium besilate, quantity: 6.69 mg/ml (equivalent: cisatracurium, qty 5 mg/ml) - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - cisatracurium mylan injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

CISATRACURIUM MYLAN cisatracurium (as besilate) 10 mg/5 mL solution for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

cisatracurium mylan cisatracurium (as besilate) 10 mg/5 ml solution for injection vial

medtas pty ltd - cisatracurium besilate, quantity: 2.68 mg/ml (equivalent: cisatracurium, qty 2 mg/ml) - injection, solution - excipient ingredients: benzenesulfonic acid; water for injections - cisatracurium mylan injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.